National Institutes of Health Grant Search

The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed) 93.855 RFA-AI-22-050
Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed) 93.853, 93.866 PAR-22-208
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed) 93.279 RFA-DA-23-017
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) 93.399 PAR-22-174
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) 93.399 PAR-22-173
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) 93.866 RFA-AG-23-033
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) 93.853, 93.866 PAS-22-197
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) 93.853, 93.866 PAS-22-196
Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required) 93.853, 93.866 RFA-NS-23-001
DoD Kidney Cancer, Clinical Trial Award 12.420 W81XWH-22-KCRP-CTA
Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional) 93.279 RFA-DA-23-011
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) 93.279 RFA-DA-23-052
Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional) 93.866 RFA-AG-23-032
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) 93.395 PAR-22-199
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) 93.395, 93.839, 93.855 RFA-CA-22-026
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) 93.395 PAR-22-198
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) 93.399 PAR-22-164
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) 93.399 PAR-22-165
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) 93.279 RFA-DA-23-019
Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed) 93.847 RFA-DK-22-001
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) 93.279 RFA-DA-23-020
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) 93.242, 93.279, 93.853 PAR-22-181
Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) 93.866 RFA-AG-23-022
Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required) 93.847 RFA-DK-22-501
Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed) 93.866 RFA-AG-23-023
Limited Competition for the Continuation of the NIDDK Diabetic Foot Consortium - Clinical Research Units (U01 Clinical Trial Optional) 93.847 RFA-DK-22-509
Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) 93.172, 93.846, 93.853, 93.855, 93.867 RFA-NS-22-051
Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional) 93.847 RFA-DK-22-006
Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed) 93.113, 93.233, 93.242, 93.307, 93.361, 93.393, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.989 RFA-ES-22-003
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) 93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.326, 93.350, 93.351, 93.361, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93 PA-22-176
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) 93.279 RFA-DA-23-015
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 PA-22-178
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) 93.113, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.859, 93.865, 93.866, 93.867 PA-22-179
PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) 93.068, 93.070, 93.073, 93.083, 93.084, 93.113, 93.136, 93.142, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.326, 93.361, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.847, 93.859, 93.865, 93.866, 93.867 PA-22-177
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) 93.233, 93.837, 93.838, 93.839, 93.840 PAR-22-194
Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences 47.049, 93.859 22-600
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) 93.855 PAR-22-185
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) 93.279, 93.855 RFA-AI-22-038
Bioprinted Tissue Constructs for Obstetric, Gynecologic, and Pediatric Applications (R01 Clinical Trial Optional) 93.865 RFA-HD-23-004
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed) 93.310 RFA-RM-22-023
Search Results 1321-1360 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com